Cardiac Mapping Companies

Abbott announced the acquisition of TactiCath®, a leading innovator in robotic navigation and ablation systems for cardiac arrhythmias, in 2023. This strategic move strengthens Abbott's position in the cardiac mapping market and expands its portfolio of interventional cardiology solutions.

Biosense Webster, a Johnson & Johnson MedTech company, launched the Octaray™ mapping catheter in 2022. This advanced catheter features eight splines, enabling more precise and efficient mapping of complex cardiac arrhythmias, particularly atrial fibrillation.

Siemens Healthineers collaborated with Acutus Medical in 2023 to integrate the AcQMap™ System with its Artis Q.ngo interventional X-ray system. This collaboration streamlines workflow and enhances visualization during cardiac mapping procedures.

Boston Scientific introduced the Carto® Ultra System in 2023. This next-generation mapping system features advanced software algorithms and artificial intelligence (AI) capabilities for improved anatomical reconstruction and arrhythmia source localization.

Medtronic launched the EnSite X™ System in 2022. This innovative system offers enhanced 3D visualization and navigation tools, along with integrated ablation delivery devices, for more efficient and precise cardiac mapping and ablation procedures.

• Abbott Laboratories


• GE Healthcare


• Boston Scientific Corporation


• Medtronic plc.


• Johnson & Johnson


• Koninklijke Philips N.V.


• Hill-Rom Services, Inc.